A33 Pill - white round, 8mm
Pill with imprint A33 is White, Round and has been identified as Oxybutynin Chloride Extended-Release 15 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.
Oxybutynin is used in the treatment of Overactive Bladder; Urinary Frequency; Urinary Incontinence; Dysuria; Neurogenic Detrusor Overactivity and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A33
Oxybutynin Chloride Extended-Release
- Imprint
- A33
- Strength
- 15 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals of New York, LLC
- Inactive Ingredients
-
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
hydrogenated cottonseed oil,
hypromelloses,
isopropyl alcohol,
lactose monohydrate,
microcrystalline cellulose,
magnesium silicate,
triethyl citrate,
polysorbate 80,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65162-0373 | Amneal Pharmaceuticals LLC |
| 10135-0611 | Marlex Pharmaceuticals Inc. |
Related images for "A33"
More about oxybutynin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (452)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: urinary antispasmodics
Patient resources
- Oxybutynin drug information
- Oxybutynin transdermal
- Oxybutynin (Oral) (Advanced Reading)
- Oxybutynin (Transdermal) (Advanced Reading)
- Oxybutynin Extended-Release Tablets
Other brands
Ditropan, Ditropan XL, Gelnique, Oxytrol, Anturol
Professional resources
Other brands
Ditropan, Ditropan XL, Gelnique, Oxytrol
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
